The store will not work correctly when cookies are disabled.
6-Amino-1'-methyl-5-(1-(pyridin-2-yl)ethoxy)[3,4'-bipyridin]-2'(1'H)-one
ID: ALA4566739
PubChem CID: 155543541
Max Phase: Preclinical
Molecular Formula: C18H18N4O2
Molecular Weight: 322.37
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CC(Oc1cc(-c2ccn(C)c(=O)c2)cnc1N)c1ccccn1
Standard InChI: InChI=1S/C18H18N4O2/c1-12(15-5-3-4-7-20-15)24-16-9-14(11-21-18(16)19)13-6-8-22(2)17(23)10-13/h3-12H,1-2H3,(H2,19,21)
Standard InChI Key: RGLAHFSQZQSICB-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
4.8694 -19.4541 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8683 -20.2814 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5830 -20.6943 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.2995 -20.2810 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2966 -19.4505 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5812 -19.0413 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1555 -19.0374 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1573 -18.2113 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4469 -17.7991 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7300 -18.2083 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.7283 -19.0342 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4433 -19.4511 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0146 -20.6923 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.4498 -16.9741 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.0095 -19.0352 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.0064 -18.2102 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7194 -17.7951 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2904 -17.8005 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4306 -18.2084 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1430 -17.7940 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1403 -16.9681 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4193 -16.5585 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7099 -16.9753 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.0171 -17.7933 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 2 0
7 12 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 2 0
1 7 1 0
4 13 1 0
9 14 2 0
5 15 1 0
15 16 1 0
16 17 1 0
16 18 1 0
17 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 17 1 0
10 24 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 322.37 | Molecular Weight (Monoisotopic): 322.1430 | AlogP: 2.56 | #Rotatable Bonds: 4 |
Polar Surface Area: 83.03 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 5.97 | CX LogP: 1.30 | CX LogD: 1.29 |
Aromatic Rings: 3 | Heavy Atoms: 24 | QED Weighted: 0.80 | Np Likeness Score: -0.87 |
References
1. Chen W, Guo X, Zhang C, Ke D, Zhang G, Yu Y.. (2019) Discovery of 2-aminopyridines bearing a pyridone moiety as potent ALK inhibitors to overcome the crizotinib-resistant mutants., 183 [PMID:31569004] [10.1016/j.ejmech.2019.111734] |